Congo begins trial of Gilead's experimental antiviral for Ebola Bundibugyo
The outbreak has led to 1,963 confirmed cases in Congo
Read the full articleYou might also wanna read
Congo begins trial of Gilead’s experimental antiviral for Ebola Bundibugyo
July 14 (Reuters) - Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in a trial test
Experimental Ebola treatments begin in Congo as outbreak grows, offering hope to affected residents
Residents in Congo's Ebola outbreak zone are hopeful as researchers begin a study of two potential treatments. The study, launched Thursday
apnews.com·11d ago
Trial of potential Ebola antiviral under way — WHO
GENEVA, Switzerland — The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola strai
Residents in eastern Congo cling to hope as a new Ebola treatment trial begins
Residents in Congo's Ebola outbreak zone are hopeful as researchers begin a study of two potential treatments
Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola
Clinical trials for treatments targeting the Bundibugyo strain of the Ebola virus disease began on July 2 in the Democratic Republic of Cong
Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola
Clinical trials for treatments targeting the Bundibugyo strain of the Ebola virus disease began on July 2 in the Democratic Republic of Cong
Vaccine trial launched in Oxford in response to deadly outbreak
A vaccine trial is under way as part of efforts to tackle the Bundibugyo ebolavirus.
Comments
Sign in to join the conversation.
No comments yet. Be the first.